市场调查报告书
商品编码
1463588
亚太地区牛隻诊断市场预测至 2030 年 - 区域分析 - 按产品、疾病类型和最终用户(兽医医院、兽医诊所和其他最终用户)Asia Pacific Bovine Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Disease Type, and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) |
亚太地区牛CAGR诊断市场预计将从2022年的2.5042亿美元成长到2030年的4.8294亿美元。
牛结核病的高盛行率推动了亚太牛诊断市场
牛结核病(bTB)是一种慢性传染病,主要影响牛,随后传播给其他动物和人类。世界动物卫生组织(WOAH)已将bTB列为必须儘早发现和报告的疾病之一。根据赛默飞世尔科技 2023 年 5 月分享的资料,bTB 影响全球超过 5,000 万头牛,每年造成约 30 亿美元的经济损失。
不同地理区域的 bTB 盛行率有所不同。然而,在亚洲某些地区,bTB 的盛行率超过 50%。儘管技术和基础设施不断发展,但由于疾病的复杂性和缺乏通用的诊断策略,许多国家未能有效诊断 bTB。这种情况为牛隻诊断市场参与者提供了提高亚洲意识并推出适合这些国家社会经济条件的新产品的机会。
亚太地区牛隻诊断市场概况
亚太地区的牛隻诊断市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。根据 2023 年 BMC 期刊发表的一篇文章,bTB 是中国的一种主要流行病,导致乳牛生产遭受重大损失。农业农村部在《国家中长期动物疫病防治规划(2012-2020年)》中,将乳牛结核病列为重点防治的16种传染病之一。人类福祉。对牛布鲁氏菌病、牛支原体病、副结核病和牛白血病等疾病进行基于牛奶的检测。牛奶样本的采集和检测对乳牛没有太大影响,这也导致乳牛工人更加配合。中国的国家乳牛群改良(DHI)计画也强调每月从泌乳牛身上采集牛奶样本,然后进行检测,以评估繁殖适宜性和牛奶品质。它还建议使用 CombiFoss FT + 牛奶成分和体细胞分析仪评估牛奶样本,以在早期阶段检测乳腺炎。中国透过检测和屠宰政策来实施目前的牛结核病控制策略,该政策以国家和地方各级以及农场的监测计画为基础。牛分枝桿菌培养是诊断 bTB 的「黄金标准」。然而,透过培养鑑定牛支原体不灵敏、繁琐、耗时,并且由于该病原体具有持续感染、生长缓慢和潜在危险的特性,需要高水准的生物安全实验室设施。目前,结核菌素皮肤试验是中国农场动物检测bTB的建议和常规测试,而血液γ干扰素体外释放试验是另一种实验室诊断测试。因此,bTB疾病的增加和政府对诊断的支持促进了中国牛隻诊断市场的成长。
亚太地区牛隻诊断市场收入及 2030 年预测(百万美元)
亚太地区牛诊断市场细分
亚太地区牛隻诊断市场按产品、疾病类型、最终用户和国家细分。
根据产品,亚太牛诊断市场分为免疫检测试剂盒、PCR 试剂和试剂盒、血凝抑制 (HI) 检测和其他产品。 2022 年,免疫分析试剂盒领域在亚太牛诊断市场中占最大份额。
根据疾病类型,亚太牛诊断市场分为牛病毒性腹泻(BVD)、牛结核病(TB)、牛乳房炎、口蹄疫(FMD)和其他疾病类型。 2022 年,牛乳房炎细分市场在亚太牛诊断市场中占据最大份额。
根据最终用户,亚太牛诊断市场分为兽医医院、兽医诊所和其他最终用户。 2022年,兽医院细分市场在亚太地区牛隻诊断市场中占据最大份额。
根据国家/地区,亚太地区牛隻诊断市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年,中国将主导亚太牛诊断市场。
BioMerieux SA、Bionote Inc、Idex Laboratories Inc、Innovative Diagnostics SAS、Neogen Corp、Ring Biotechnology Co Ltd、深圳市易易生物科技有限公司和 Thermo Fisher Scientific Inc 是亚太牛诊断市场上的一些领先公司。
The Asia Pacific bovine diagnostics market is expected to grow from US$ 250.42 million in 2022 to US$ 482.94 million by 2030. It is estimated to grow at a CAGR of 8.6% from 2022 to 2030.
High Prevalence of Bovine Tuberculosis Fuels Asia Pacific Bovine Diagnostics Market
Bovine tuberculosis (bTB) is a chronic infectious disease that primarily affects cattle and is later transmitted to other animals and humans. The World Organization for Animal Health (WOAH) has listed bTB as one of the diseases that must be detected and reported as earliest as possible. As per the data shared by Thermo Fisher Scientific in May 2023, bTB affects more than 50 million cattle worldwide, incurring annual economic losses of ~US$ 3 billion.
The prevalence of bTB differs in different geographic areas. However, its prevalence reaches beyond bTB 50% in some parts of Asia. Despite the ongoing technological and infrastructural developments, many countries fail to effectively diagnose bTB due to the complexity of the disease and the lack of universal strategies for its diagnosis. This scenario provides opportunities for bovine diagnostics market players to enhance awareness in Asia and launch new products that suit the socioeconomic conditions in these countries.
Asia Pacific Bovine Diagnostics Market Overview
The Asia Pacific bovine diagnostics market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. According to an article published in BMC Journals in 2023, bTB is a major endemic in China that results in major losses in dairy cattle production. In its Medium and Long-Term National Plan for Prevention and Control of Animal Diseases (2012-2020), the Ministry of Agriculture and Rural Affairs in China has classified the bTB of dairy cattle as one of the 16 infectious diseases that should be controlled and eliminated, as the disease also affects human welfare in addition to the livestock industry. A milk-based test is performed for diseases such as bovine brucellosis, Mycoplasma bovis (M. bovis) disease, paratuberculosis, and bovine leukosis. The collection and testing of milk samples do not have much impact on dairy cows, which also results in greater cooperation from dairy workers. The National Dairy Herd Improvement (DHI) Program of China also emphasizes on the collection of milk samples from lactating cows monthly, followed by testing them to assess breeding suitability and milk quality. It also recommends evaluating the milk samples to detect mastitis in the early stages using a CombiFoss FT + milk composition and a somatic cell analyzer. China implements its current bTB control strategy through test-and-slaughter policies, which are based on surveillance programs at the national and local levels, as well as on farms. Mycobacterium bovis culture is the "gold standard" for diagnosing bTB. However, the identification of M. bovis by culturing it is insensitive, cumbersome, and time-consuming, and it requires high-level biosafety laboratory facilities because of the persistent infection, slow growth, and potentially dangerous characteristics of the pathogen. Currently, the tuberculin skin test is the recommended and conventional test performed on animals at farms in China for detecting bTB, while the blood interferon-gamma in vitro release test is an alternative laboratory diagnostic test available. Thus, increasing bTB disease and support by government for diagnosis boosts the growth of bovine diagnostics market growth in China.
Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Bovine Diagnostics Market Segmentation
The Asia Pacific bovine diagnostics market is segmented into product, disease type, end user, and country.
Based on product, the Asia Pacific bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.
Based on disease type, the Asia Pacific bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.
Based on end user, the Asia Pacific bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.
Based on country, the Asia Pacific bovine diagnostics market is segmented int o China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bovine diagnostics market in 2022.
bioMerieux SA, Bionote Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, Ring Biotechnology Co Ltd, Shenzhen Bioeasy Biotechnology Co Ltd, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific bovine diagnostics market.